Actively Recruiting
" TREX1 Gene Mutations and Their Role in Systemic Lupus Erythematosus
Led by South Valley University · Updated on 2026-02-09
90
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterized by diverse clinical manifestations, prominently involving the skin.
CONDITIONS
Official Title
" TREX1 Gene Mutations and Their Role in Systemic Lupus Erythematosus
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult aged 18-60 years
- Diagnosed as SLE per 2019 EULAR/ACR classification criteria
- Presence of at least one cutaneous manifestation (acute, subacute, or chronic)
- Willing to provide written informed consent for participation and genetic testing
You will not qualify if you...
- Overlap autoimmune syndromes (e.g., dermatomyositis, systemic sclerosis)
- Systemic infection, malignancy, or pregnancy
- Use of biologic therapy or immunosuppressive pulses within one month
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Qina University hospital, South Valley University Hospital
Qina, South Valley, Egypt
Actively Recruiting
Research Team
A
Amira Rabea AbuElfadl, MSc
CONTACT
S
Soheir Abdel-hamid Ali, Lecturer
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here